OPUS 4 | Search

7 search hits

1 to 7

Sort by

Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status: an analysis from the acute leukemia working party of the EBMT (2021)

Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients (2020)

Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) (2018)

Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: a position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2016)

Giebel, Sebastian ; Czyz, Anna ; Ottmann, Oliver ; Baron, Frederic ; Brissot, Eolia ; Ciceri, Fabio ; Cornelissen, Jan J. ; Esteve, Jordi ; Gorin, Norbert-Claude ; Savani, Bipin ; Schmid, Christoph ; Mohty, Mohamad ; Nagler, Arnon

Allogeneic Hematopoietic Cell Transplantation (alloHCT) for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 (MLL/AF4) B-Acute Lymphoblastic Leukemia in first complete remission (CR1): favorable outcome of patients with negative Minimal Residual Disease (MRD) status at transplant. A report from the Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation (ALWP-EBMT) (2017)

1 to 7